Savarirayan, R. Et Al. 2024. GROWTH-PROMOTING EFFECTS OF VOSORITIDE IN CHILDREN WITH ACHONDROPLASIA AGED=10 YEARS AT TREATMENT INITIATION: RESULTS FROM A PHASE 3 EXTENSION STUDY. HORMONE RESEARCH IN PAEDIATRICS , 172-174.

Savarirayan, R., Tofts, L., Irving, M., Wilcox, W. R., Bacino, C. A., Harmatz, P. R., ... Rutsch, F.(2024). GROWTH-PROMOTING EFFECTS OF VOSORITIDE IN CHILDREN WITH ACHONDROPLASIA AGED=10 YEARS AT TREATMENT INITIATION: RESULTS FROM A PHASE 3 EXTENSION STUDY. HORMONE RESEARCH IN PAEDIATRICS , 172-174.

Savarirayan, Ravi Et Al. "GROWTH-PROMOTING EFFECTS OF VOSORITIDE IN CHILDREN WITH ACHONDROPLASIA AGED=10 YEARS AT TREATMENT INITIATION: RESULTS FROM A PHASE 3 EXTENSION STUDY," HORMONE RESEARCH IN PAEDIATRICS , 172-174, 2024

Savarirayan, Ravi Et Al. "GROWTH-PROMOTING EFFECTS OF VOSORITIDE IN CHILDREN WITH ACHONDROPLASIA AGED=10 YEARS AT TREATMENT INITIATION: RESULTS FROM A PHASE 3 EXTENSION STUDY." HORMONE RESEARCH IN PAEDIATRICS , pp.172-174, 2024

Savarirayan, R. Et Al. (2024) . "GROWTH-PROMOTING EFFECTS OF VOSORITIDE IN CHILDREN WITH ACHONDROPLASIA AGED=10 YEARS AT TREATMENT INITIATION: RESULTS FROM A PHASE 3 EXTENSION STUDY." HORMONE RESEARCH IN PAEDIATRICS , pp.172-174.

@article{article, author={Ravi Savarirayan Et Al. }, title={GROWTH-PROMOTING EFFECTS OF VOSORITIDE IN CHILDREN WITH ACHONDROPLASIA AGED=10 YEARS AT TREATMENT INITIATION: RESULTS FROM A PHASE 3 EXTENSION STUDY}, journal={HORMONE RESEARCH IN PAEDIATRICS}, year=2024, pages={172-174} }